ciprofloxacin
- Product NDC
- 50090-1648
- 11-digit product format
- 500901648
- Labeler code
- 50090
- Product ID
- 50090-1648_5f4acec7-3462-49b9-962c-931fedc0f520
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ciprofloxacin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA076639
- Marketing category
- ANDA
- Marketing start
- 2004-09-10
- Substance
- CIPROFLOXACIN HYDROCHLORIDE
- Active strength
- 500 mg/1
- Pharmacologic classes
- Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- ciprofloxacin
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CIPROFLOXACIN HYDROCHLORIDE | 500 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 4BA73M5E37 |
| Rxcui | 309309 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 50090-1648-0 | 2024-01-04 | C162847 | 48780-1 | f386c64a-14b6-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use CIPROFLOXACIN TABLETS safely and effectively. See full prescribing information for CIPROFLOXACIN TABLETS. CIPROFLOXACIN tablet, for oral use Initial U.S. Approval: 1987 |
| 50090-1648-1 | 2024-01-04 | C162847 | 48780-1 | f386c64a-14b6-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use CIPROFLOXACIN TABLETS safely and effectively. See full prescribing information for CIPROFLOXACIN TABLETS. CIPROFLOXACIN tablet, for oral use Initial U.S. Approval: 1987 |
| 50090-1648-3 | 2024-01-04 | C162847 | 48780-1 | f386c64a-14b6-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use CIPROFLOXACIN TABLETS safely and effectively. See full prescribing information for CIPROFLOXACIN TABLETS. CIPROFLOXACIN tablet, for oral use Initial U.S. Approval: 1987 |
| 50090-1648-4 | 2024-01-04 | C162847 | 48780-1 | f386c64a-14b6-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use CIPROFLOXACIN TABLETS safely and effectively. See full prescribing information for CIPROFLOXACIN TABLETS. CIPROFLOXACIN tablet, for oral use Initial U.S. Approval: 1987 |
| 50090-1648-5 | 2024-01-04 | C162847 | 48780-1 | f386c64a-14b6-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use CIPROFLOXACIN TABLETS safely and effectively. See full prescribing information for CIPROFLOXACIN TABLETS. CIPROFLOXACIN tablet, for oral use Initial U.S. Approval: 1987 |
| 50090-1648-7 | 2024-01-04 | C162847 | 48780-1 | f386c64a-14b6-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use CIPROFLOXACIN TABLETS safely and effectively. See full prescribing information for CIPROFLOXACIN TABLETS. CIPROFLOXACIN tablet, for oral use Initial U.S. Approval: 1987 |
| 50090-1648-8 | 2024-01-04 | C162847 | 48780-1 | f386c64a-14b6-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use CIPROFLOXACIN TABLETS safely and effectively. See full prescribing information for CIPROFLOXACIN TABLETS. CIPROFLOXACIN tablet, for oral use Initial U.S. Approval: 1987 |
| 50090-1648-9 | 2024-01-04 | C162847 | 48780-1 | f386c64a-14b6-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use CIPROFLOXACIN TABLETS safely and effectively. See full prescribing information for CIPROFLOXACIN TABLETS. CIPROFLOXACIN tablet, for oral use Initial U.S. Approval: 1987 |
| 50090-1648-0 | 2023-01-30 | C162847 | 48780-1 | f386c64a-14b6-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use CIPROFLOXACIN TABLETS safely and effectively. See full prescribing information for CIPROFLOXACIN TABLETS. CIPROFLOXACIN tablet, for oral use Initial U.S. Approval: 1987 |
| 50090-1648-1 | 2023-01-30 | C162847 | 48780-1 | f386c64a-14b6-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use CIPROFLOXACIN TABLETS safely and effectively. See full prescribing information for CIPROFLOXACIN TABLETS. CIPROFLOXACIN tablet, for oral use Initial U.S. Approval: 1987 |
| 50090-1648-3 | 2023-01-30 | C162847 | 48780-1 | f386c64a-14b6-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use CIPROFLOXACIN TABLETS safely and effectively. See full prescribing information for CIPROFLOXACIN TABLETS. CIPROFLOXACIN tablet, for oral use Initial U.S. Approval: 1987 |
| 50090-1648-4 | 2023-01-30 | C162847 | 48780-1 | f386c64a-14b6-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use CIPROFLOXACIN TABLETS safely and effectively. See full prescribing information for CIPROFLOXACIN TABLETS. CIPROFLOXACIN tablet, for oral use Initial U.S. Approval: 1987 |
| 50090-1648-5 | 2023-01-30 | C162847 | 48780-1 | f386c64a-14b6-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use CIPROFLOXACIN TABLETS safely and effectively. See full prescribing information for CIPROFLOXACIN TABLETS. CIPROFLOXACIN tablet, for oral use Initial U.S. Approval: 1987 |
| 50090-1648-7 | 2023-01-30 | C162847 | 48780-1 | f386c64a-14b6-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use CIPROFLOXACIN TABLETS safely and effectively. See full prescribing information for CIPROFLOXACIN TABLETS. CIPROFLOXACIN tablet, for oral use Initial U.S. Approval: 1987 |
| 50090-1648-8 | 2023-01-30 | C162847 | 48780-1 | f386c64a-14b6-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use CIPROFLOXACIN TABLETS safely and effectively. See full prescribing information for CIPROFLOXACIN TABLETS. CIPROFLOXACIN tablet, for oral use Initial U.S. Approval: 1987 |
| 50090-1648-9 | 2023-01-30 | C162847 | 48780-1 | f386c64a-14b6-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use CIPROFLOXACIN TABLETS safely and effectively. See full prescribing information for CIPROFLOXACIN TABLETS. CIPROFLOXACIN tablet, for oral use Initial U.S. Approval: 1987 |
DailyMed Package Descriptions#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50090-1648 | CIPROFLOXACIN TABLET [A-S MEDICATION SOLUTIONS] | 23 | Current NDC, Legacy NDC, 8 package rows | 20250410_c12b316f-811c-48b6-a320-d314991aa74f.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50090-1648-0 | 50090164800 | 20 TABLET in 1 BOTTLE (50090-1648-0) | 20 tablet | 2015-01-19 | 0000-00-00 | No | No | Current |
| 50090-1648-1 | 50090164801 | 14 TABLET in 1 BOTTLE (50090-1648-1) | 14 tablet | 2015-01-19 | 0000-00-00 | No | No | Current |
| 50090-1648-3 | 50090164803 | 6 TABLET in 1 BOTTLE (50090-1648-3) | 6 tablet | 2015-01-19 | 0000-00-00 | No | No | Current |
| 50090-1648-4 | 50090164804 | 28 TABLET in 1 BOTTLE (50090-1648-4) | 28 tablet | 2015-01-19 | 0000-00-00 | No | No | Current |
| 50090-1648-5 | 50090164805 | 10 TABLET in 1 BOTTLE (50090-1648-5) | 10 tablet | 2015-01-19 | 0000-00-00 | No | No | Current |
| 50090-1648-7 | 50090164807 | 30 TABLET in 1 BOTTLE (50090-1648-7) | 30 tablet | 2015-01-19 | 0000-00-00 | No | No | Current |
| 50090-1648-8 | 50090164808 | 1 TABLET in 1 BOTTLE (50090-1648-8) | 1 tablet | 2018-05-22 | 0000-00-00 | No | No | Current |
| 50090-1648-9 | 50090164809 | 100 TABLET in 1 BOTTLE (50090-1648-9) | 100 tablet | 2017-07-27 | 0000-00-00 | No | No | Current |